How much does Erbitux (Cetuximab Solution for Infusion) Cost& price without insurance in China?
Erbitux® is the commercial brand name of Cetuximab Solution for Infusion, a chimeric monoclonal antibody against the epidermal growth factor receptor (EGFR) developed by Merck Serono. It binds to EGFR and blocks downstream signaling pathways, inhibiting tumor cell proliferation, invasion, and metastasis.
Main Indications
Treatment of metastatic colorectal cancer with wild-type RAS/BRAF status, used in combination with chemotherapy or as monotherapy.
First-line treatment of locally advanced squamous cell carcinoma of the head and neck in combination with platinum-based chemotherapy and 5-fluorouracil.
Common Side Effects
Common mild adverse reactions: Acne-like rash, fatigue, nausea, vomiting, and diarrhea.
Laboratory abnormalities: Hypomagnesemia, hypokalemia, and elevated liver enzymes.
Severe but uncommon risks: Severe infusion reactions, interstitial lung disease, severe skin toxicity, and electrolyte disturbances.
Approval Status in China
Erbitux® (Cetuximab Solution for Infusion, 100mg/20mL) was officially approved for marketing in China in 2005. It is currently a prescription anti-tumor drug included in China’s Category B medical insurance.
Buy Erbitux (Cetuximab Solution for Infusion) online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
